Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
Vertex's pain prospect underwhelms versus placebo, sinking stock
The trial linked the molecule to a significant improvement from baseline, but placebo performed similarly, triggering a 12% drop in Vertex’s share.
Nick Paul Taylor
Dec 19, 2024 7:41am
Cognition's phase 2 SHIMMER results allow dementia drug to shine
Dec 18, 2024 7:00am
PureTech's lung fibrosis drug slows decline in phase 2 trial
Dec 16, 2024 7:00am
Anaptys scraps atopic dermatitis asset after ph. 2 fail
Dec 11, 2024 11:02am
Candel burns bright as phase 3 cancer win sends stock up 200%
Dec 11, 2024 9:49am
BioNTech posts overall survival data on would-be Keytruda killer
Dec 10, 2024 9:00am
